Trametinib, desacetyl

Details

Stereochemistry	ACHIRAL
Molecular Formula	C24H21FIN5O3
Molecular Weight	573.3581
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC4=C(F)C=C(I)C=C4)C5=CC(N)=CC=C5

InChI

InChIKey=JHOKCEWWVHBOFH-UHFFFAOYSA-N

InChI=1S/C24H21FIN5O3/c1-12-20-19(21(29(2)22(12)32)28-18-9-6-13(26)10-17(18)25)23(33)31(15-7-8-15)24(34)30(20)16-5-3-4-14(27)11-16/h3-6,9-11,15,28H,7-8,27H2,1-2H3

HIDE SMILES / InChI

Molecular Formula	C24H21FIN5O3
Molecular Weight	573.3581
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 23:30:57 GMT 2025` Edited by `admin` on `Mon Mar 31 23:30:57 GMT 2025`
Record UNII	5WO96J6LES
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Trametinib, desacetyl

Common Name

English

GSK-1790627

Preferred Name

English

TRAMETINIB METABOLITE M5

Common Name

English

PYRIDO(4,3-D)PYRIMIDINE-2,4,7(1H,3H,6H)-TRIONE, 1-(3-AMINOPHENYL)-3-CYCLOPROPYL-5-((2-FLUORO-4-IODOPHENYL)AMINO)-6,8-DIMETHYL-

Systematic Name

English

TRAMETINIB METABOLITE M1

Common Name

English

GSK1790627

Code

English

1-(3-AMINOPHENYL)-3-CYCLOPROPYL-5-((2-FLUORO-4-IODOPHENYL)AMINO)-6,8-DIMETHYL-2,4,7-TRIOXO-3,4,6,7-TETRAHYDRO-2H-PYRIDO(4,3-D)PYRIMIDINE

Systematic Name

English

Code System Code Type Description

CAS

871701-87-0

Created by admin on Mon Mar 31 23:30:57 GMT 2025 , Edited by admin on Mon Mar 31 23:30:57 GMT 2025

PRIMARY

FDA UNII

5WO96J6LES

Created by admin on Mon Mar 31 23:30:57 GMT 2025 , Edited by admin on Mon Mar 31 23:30:57 GMT 2025

PRIMARY

PUBCHEM

59717278

Created by admin on Mon Mar 31 23:30:57 GMT 2025 , Edited by admin on Mon Mar 31 23:30:57 GMT 2025

PRIMARY

Related Record Type Details


					33E86K87QN

Trametinib

PARENT -> METABOLITE ACTIVE

Comments:

Unit: percent of administrated dose; Pooled feces (48-240hr); Subject A

Interaction Type:

IN-VIVO

Qualification:

FECAL

Amount:


					33E86K87QN

Trametinib

PARENT -> METABOLITE ACTIVE

Comments:

Unit: percent of plasma radioactivity; 48hr; Subject A

Interaction Type:

IN-VIVO

Qualification:

PLASMA

Amount:


					33E86K87QN

Trametinib

PARENT -> METABOLITE ACTIVE

Comments:

Unit: percent of administrated dose; 240hr total; Subject A

Interaction Type:

IN-VIVO

Qualification:

URINE

Amount:


					33E86K87QN

Trametinib

PARENT -> METABOLITE ACTIVE

Comments:

Unit: percent of blood radioactivity; "Late pool" Whole blood at 4, 6, 8, 10hr; Subject A

Interaction Type:

IN-VIVO

Amount: